BRIEF published on 08/20/2025 at 23:35, 1 year 2 months ago Medicure Reports Q2 2025 Financial Results Financial Results Net Loss Net Revenue Research Investment Pharmaceutical Business
PRESS RELEASE published on 08/20/2025 at 23:30, 1 year 2 months ago Medicure Reports Financial Results for Quarter Ended June 30, 2025 Medicure Inc. reports Q2 2025 financial results, including increased revenue from Marley Drug and ZYPITAMAG(R), and enhanced adjusted EBITDA. Find full details at www.medicure.com Financial Results Medicure Inc. Marley Drug ZYPITAMAG Q2 2025
BRIEF published on 08/18/2025 at 23:35, 1 year 2 months ago Medicure to Announce Q2 2025 Financial Results via Conference Call Financial Results Conference Call Pharmaceuticals Medicure Q2 2025
PRESS RELEASE published on 08/18/2025 at 23:30, 1 year 2 months ago Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 Medicure Inc. to present Financial Results for Q2 2025 on August 21, 2025 via conference call. Operations and products focus detailed Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 06/17/2025 at 23:05, 1 year 4 months ago Medicure Finalizes Acquisition of West Olympia Pharmacy Acquisition Revenue Growth Pharmaceuticals Pharmacy Medicure
PRESS RELEASE published on 06/17/2025 at 23:00, 1 year 4 months ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
BRIEF published on 05/21/2025 at 23:05, 1 year 5 months ago Medicure Announces Q1 2025 Financial Results and Director Election Outcomes Net Loss Director Election Medicure Financial Results AGGRASTAT Sales Decline Pharmacy Revenue
PRESS RELEASE published on 05/21/2025 at 23:00, 1 year 5 months ago Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2025 results with $5.5M net revenue, elects directors, and details financial performance. AGGRASTAT and ZYPITAMAG sales analyzed Medicure Inc. Net Revenue AGGRASTAT ZYPITAMAG Q1 2025 Results
BRIEF published on 04/25/2025 at 23:06, 1 year 6 months ago Medicure Inc. Reveals Financial Results for 2024 Medicure Inc. 2024 AGGRASTAT® Sales ZYPITAMAG® Revenue Marley Drug Financials Adjusted EBITDA Decline
PRESS RELEASE published on 04/25/2025 at 23:01, 1 year 6 months ago Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024 Medicure Inc. reports total net revenue of $21.9 million for year ended Dec 31, 2024. AGGRASTAT & Marley Drug sales increase, while Adjusted EBITDA declines Adjusted EBITDA Medicure Inc. Marley Drug Net Revenue AGGRASTAT
Published on 11/03/2026 at 17:30, 4 hours 15 minutes ago Western Raises Gross Proceeds of Over $55.8 Million on Closing of Previously Announced Private Placement
Published on 11/03/2026 at 15:30, 6 hours 15 minutes ago Murchison Minerals Announces $1 Million Non-Brokered Private Placement
Published on 11/03/2026 at 15:05, 6 hours 40 minutes ago ACCESS Newswire to Host Third Quarter Earnings Conference Call on November 10, 2026
Published on 11/03/2026 at 14:31, 7 hours 14 minutes ago First Breach Adds Inspection Equipment and Secures Strategic Supply Agreements to Support Ammunition Production
Published on 11/03/2026 at 14:00, 7 hours 45 minutes ago Global Education Communities Corp. Provides Corporate Update on Student Housing Portfolio and Development Projects
Published on 11/03/2026 at 19:30, 2 hours 15 minutes ago Africa and Caribbean trade potential could reach $1.65 billion annually by 2030: International Trade Centre (ITC)-Afreximbank report
Published on 11/03/2026 at 17:45, 4 hours ago BILENDI: Bilendi returns to slight revenue growth in Q3 2026
Published on 11/03/2026 at 17:34, 4 hours 11 minutes ago EQS-Adhoc: fox e-mobility AG: Convocation AGM 2026 with proposed resolutions for capital increases in the vehicle production and wind energy sectors and presentation of the 2025 annual statements
Published on 11/03/2026 at 17:30, 4 hours 14 minutes ago Kudelski Labs and u-blox Expand Strategic Collaboration to Deliver Next-Generation Secure Semiconductor Platforms
Published on 11/03/2026 at 18:00, 3 hours 45 minutes ago Outstanding Shares and Voting Rights Monthly Statement - 31 October 2026
Published on 11/03/2026 at 17:45, 4 hours ago Declaration of voting rights at the end of October 2026
Published on 11/03/2026 at 07:00, 14 hours 45 minutes ago bioMérieux – Third-Quarter 2026 Business Review
Published on 11/02/2026 at 18:30, 1 day 3 hours ago Disclosure of transactions in own shares from October 26 to October 30, 2026
